There is no evidence of reliable molecular prognostic factors for osteosarcoma, but the expression of P‐glycoprotein (Pgp), an efflux pump that removes chemotherapeutic drugs from cells, has been associated with poorer survival in patients affected by osteosarcoma (41). This evidence concerns the gene PGP and osteosarcoma.